[#item_full_content] “The purpose is to turn up the heat and get resources to develop these more natural options that could be very important.” By Jack Gorsline, Psychedelic State(s) of America As cannabis rescheduling efforts under the Trump administration draw closer to finalization and Food and Drug Administration (FDA) approval of the first wave of synthetic psychedelic 
Read More
New Congressional Bill Could Boost Development Of Plant-Based Medicines, Including Those Derived From Cannabis Or Psychedelics
ByPot Shop News
September 15, 2026